Literature DB >> 2187454

The involvement of Ly2+ T cells in beta cell destruction.

P R Hutchings1, E Simpson, L A O'Reilly, T Lund, H Waldmann, A Cooke.   

Abstract

The non-obese diabetic (NOD) mouse is considered to be a good model of human Type I diabetes mellitus. Both sexes develop insulitis starting at about 6 weeks of age, and onset of diabetes follows at about 30 weeks in females, but later and much less frequently in males. In some mice (but not all) infiltration of the islets leads to selective destruction of insulin-producing beta cells, which is marked by clinically overt diabetes and is thought to be an autoimmune response mediated by T cells. Both L3T4+ and Ly2+ cells have been implicated in the destructive process and we have used an in vivo transfer system, together with histological studies on the pancreas, to demonstrate the essential role played by Ly2+ T cells in the destruction of beta cells in diabetic mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187454     DOI: 10.1016/s0896-8411(09)90018-x

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  15 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse.

Authors:  J Strid; L Lopes; J Marcinkiewicz; L Petrovska; B Nowak; B M Chain; T Lund
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 3.  Mechanisms of transplantation immunity.

Authors:  E Simpson
Journal:  Springer Semin Immunopathol       Date:  1992

Review 4.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

5.  Mechanisms of Mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells.

Authors:  T C Martins; A P Aguas
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 6.  Temporal discontinuities in progression of NOD autoimmune diabetes.

Authors:  G B Rudy; R M Sutherland; A M Lew
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

7.  Involvement of c-myc in the resistance of non-obese diabetic mice to glucocorticoid-induced apoptosis.

Authors:  T C Martins; A P Aguas
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

8.  In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice.

Authors:  D Healey; P Ozegbe; S Arden; P Chandler; J Hutton; A Cooke
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

9.  Mechanisms of beta cell death in diabetes: a minor role for CD95.

Authors:  J Allison; A Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Type 1 diabetes development requires both CD4+ and CD8+ T cells and can be reversed by non-depleting antibodies targeting both T cell populations.

Authors:  Jenny M Phillips; Nicole M Parish; Tim Raine; Chris Bland; Yvonne Sawyer; Hugo De La Peña; Anne Cooke
Journal:  Rev Diabet Stud       Date:  2009-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.